Harald von Melchner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Harald von Melchner has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Frank Schnütgen
Goethe University Frankfurt, Department of Medicine, Hematology/Oncology, Frankfurt/Main, Germany
7 shared publications Frank Wempe
Department of Molecular Hematology, Goethe University Medical School, D-60590 Frankfurt am Main, Germany
5 shared publicationsAna Tomasovic
Department of Molecular Hematology, Goethe University Medical School, 60590 Frankfurt am Main, Germany
4 shared publications- Norbert Weissmann
Excellence Cluster Cardio-Pulmonary Institute (CPI), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University of Giessen, Aulweg 130, 35392 Giessen, Germany
4 shared publications Silke De-Zolt
Department of Molecular Hematology, Goethe University Medical School, D-60590 Frankfurt am Main, Germany
4 shared publicationsAnja Sterner-Kock
Center for Experimental Medicine, Medical Faculty, University of Cologne, 50931 Cologne, Germany
3 shared publications
Latest Publications
- Open Access
- 1 March 2018
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 10, 1-8
High Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
- 1 March 2018
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 10, 1-8
Open AccessHigh Efficiency Gene Correction in Hematopoietic Cells by Donor-Template-Free CRISPR/Cas9 Genome Editing
- Open Access
- 17 September 2016
- Published by Elsevier in Matrix Biology
- Vol. 59, 109-120
Ltbp4 regulates Pdgfrβ expression via TGFβ-dependent modulation of Nrf2 transcription factor function
- 17 September 2016
- Published by Elsevier in Matrix Biology
- Vol. 59, 109-120
Open AccessLtbp4 regulates Pdgfrβ expression via TGFβ-dependent modulation of Nrf2 transcription factor function
- Open Access
- 1 April 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (15) , 9738-9752
Sestrin 2 Protein Regulates Platelet-derived Growth Factor Receptor β (Pdgfrβ) Expression by Modulating Proteasomal and Nrf2 Transcription Factor Functions
- 1 April 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (15) , 9738-9752
Open AccessSestrin 2 Protein Regulates Platelet-derived Growth Factor Receptor β (Pdgfrβ) Expression by Modulating Proteasomal and Nrf2 Transcription Factor Functions
- Open Access
- 1 January 2013
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 6 (6) , 1378-87
Sestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD
Summary: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD is caused by chronic exposure to cigarette smoke and/or other environmental pollutants that are believed to induce reactive oxygen species (ROS) that gradually disrupt signalling pathways responsible for maintaining lung integrity. Here we identify the antioxidant protein sestrin-2 (SESN2) as a repressor of PDGFRβ signalling, and PDGFRβ signalling as an upstream regulator of alveolar maintenance programmes. In mice, the mutational inactivation of Sesn2 prevents the development of cigarette-smoke-induced pulmonary emphysema by upregulating PDGFRβ expression via a selective accumulation of intracellular superoxide anions (O2-). We also show that SESN2 is overexpressed and PDGFRβ downregulated in the emphysematous lungs of individuals with COPD and to a lesser extent in human lungs of habitual smokers without COPD, implicating a negative SESN2-PDGFRβ interrelationship in the pathogenesis of COPD. Taken together, our results imply that SESN2 could serve as both a biomarker and as a drug target in the clinical management of COPD.
- 1 January 2013
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 6 (6) , 1378-87
Open AccessSestrin-2, a repressor of PDGFRβ signalling, promotes cigarette-smoke-induced pulmonary emphysema in mice and is upregulated in individuals with COPD
Summary: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD is caused by chronic exposure to cigarette smoke and/or other environmental pollutants that are believed to induce reactive oxygen species (ROS) that gradually disrupt signalling pathways responsible for maintaining lung integrity. Here we identify the antioxidant protein sestrin-2 (SESN2) as a repressor of PDGFRβ signalling, and PDGFRβ signalling as an upstream regulator of alveolar maintenance programmes. In mice, the mutational inactivation of Sesn2 prevents the development of cigarette-smoke-induced pulmonary emphysema by upregulating PDGFRβ expression via a selective accumulation of intracellular superoxide anions (O2-). We also show that SESN2 is overexpressed and PDGFRβ downregulated in the emphysematous lungs of individuals with COPD and to a lesser extent in human lungs of habitual smokers without COPD, implicating a negative SESN2-PDGFRβ interrelationship in the pathogenesis of COPD. Taken together, our results imply that SESN2 could serve as both a biomarker and as a drug target in the clinical management of COPD.
- Open Access
- 8 March 2010
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 3 (3-4) , 246-253
Inactivation of sestrin 2 induces TGF-β signaling and partially rescues pulmonary emphysema in a mouse model of COPD
SUMMARY Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Cigarette smoking has been identified as one of the major risk factors and several predisposing genetic factors have been implicated in the pathogenesis of COPD, including a single nucleotide polymorphism (SNP) in the latent transforming growth factor (TGF)-β binding protein 4 (Ltbp4)-encoding gene. Consistent with this finding, mice with a null mutation of the short splice variant of Ltbp4 (Ltbp4S) develop pulmonary emphysema that is reminiscent of COPD. Here, we report that the mutational inactivation of the antioxidant protein sestrin 2 (sesn2) partially rescues the emphysema phenotype of Ltbp4S mice and is associated with activation of the TGF-β and mammalian target of rapamycin (mTOR) signal transduction pathways. The results suggest that sesn2 could be clinically relevant to patients with COPD who might benefit from antagonists of sestrin function.
- 8 March 2010
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 3 (3-4) , 246-253
Open AccessInactivation of sestrin 2 induces TGF-β signaling and partially rescues pulmonary emphysema in a mouse model of COPD
SUMMARY Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Cigarette smoking has been identified as one of the major risk factors and several predisposing genetic factors have been implicated in the pathogenesis of COPD, including a single nucleotide polymorphism (SNP) in the latent transforming growth factor (TGF)-β binding protein 4 (Ltbp4)-encoding gene. Consistent with this finding, mice with a null mutation of the short splice variant of Ltbp4 (Ltbp4S) develop pulmonary emphysema that is reminiscent of COPD. Here, we report that the mutational inactivation of the antioxidant protein sestrin 2 (sesn2) partially rescues the emphysema phenotype of Ltbp4S mice and is associated with activation of the TGF-β and mammalian target of rapamycin (mTOR) signal transduction pathways. The results suggest that sesn2 could be clinically relevant to patients with COPD who might benefit from antagonists of sestrin function.
- 1 August 2007
- Published by Springer Nature in Nature Genetics
- Vol. 39 (8) , 933-934
Splinkerette PCR for more efficient characterization of gene trap events
- 1 August 2007
- Published by Springer Nature in Nature Genetics
- Vol. 39 (8) , 933-934
Splinkerette PCR for more efficient characterization of gene trap events